Viewpoints

Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity

Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity

Acute peripheral neuropathy often does not resolve between cycles of treatment and severity often increases between cycles.

PRO-CTCAE Provides "Missing Patient Voice" in Reporting Cancer Treatment Symptoms

PRO-CTCAE Provides "Missing Patient Voice" in Reporting Cancer Treatment Symptoms

A prescription drug's label AE section is almost entirely based on clinicians' impression of patients' symptoms, not the patients' own reports.

Feature Articles

We Can Treat Hodgkin's Lymphoma Like Melanoma?

We Can Treat Hodgkin's Lymphoma Like Melanoma?

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Skin Cancer Resources

More Skin Cancer Information

Melanoma: Causes, Symptoms, and Prevention

This fact sheet offers tips to decrease the risk of malignant melanoma, the fastest growing forms of skin cancer.

Melanoma Risk Factors and Screening

This patient fact sheet describes risk factors and preventative measures in skin cancer, malignant melanoma.

How Cancer Patients Can Stay Safe in the Sun

This fact sheet helps cancer patients learn what they can do to protect themselves from skin cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs